Key Takeaways
- • Strategic Misalignment: Warburg Pincus (45% stake) and co-founder Francisco Fernandez (28% stake) clashed over investment timelines—private equity's typical 3-5 year exit versus Fernandez's long-term vision for the Zurich-based banking software firm.
- • Failed Capital Injection: The $367 million (350 million Swiss francs) that Warburg Pincus deployed in 2017 was used to purchase existing shares from founders rather than fund a capital increase, leaving Avaloq to finance strategic shifts from existing cash flow and constraining profitability relative to competitors.
- • Minority Position Constraint: Warburg Pincus's inability to secure a controlling majority prevented execution of its investment thesis, positioning the shareholder exit as a strategic necessity rather than optimal timing.
- • Pending Sale Process: Avaloq, advised by Goldman Sachs and Barclays, is evaluating a sale expected to value the company at approximately $2 billion, with a decision timeline of weeks as of the June 2020 reporting date.
Summary
A fundamental strategic divergence between Warburg Pincus and Avaloq co-founder Francisco Fernandez has precipitated the private equity firm's exit from the banking software company, according to finews.com sources. The dispute centered on competing investment philosophies: Fernandez, who retains the chairman role and 28% ownership, prioritized long-term value creation and transformation initiatives, while Warburg Pincus—commanding 45% and two board seats—operated within the conventional 3-5 year private equity investment cycle demanding near-term profitability acceleration.
One source characterized the dynamic as "a clash of a visionary co-founder who had trouble putting his plans into reality versus an experienced financial investor working through a fairly rigid three- to five-year investment case." This structural mismatch became particularly acute given Warburg Pincus's inability to enforce its strategic agenda without majority control, a critical constraint that hindered realization of its original investment thesis.
A structural impediment compounded the relationship's deterioration: the $367 million (350 million Swiss francs) that Warburg Pincus deployed in 2017 was structured as a share purchase from existing co-founders Francisco Fernandez and Ronald Straessler rather than a direct capital injection into Avaloq. Consequently, the company received no fresh capital and was forced to finance its strategic pivot from operating cash flow—a constraint that has contributed to Avaloq's profitability lagging behind competitors, as previously reported by finews.com.
Avaloq, advised by Goldman Sachs and Barclays, is conducting a formal sale process with an anticipated valuation target of approximately $2 billion. According to sources familiar with the matter, the company is expected to reach a decision on its disposition strategy within weeks of the June 24, 2020 reporting date. Neither Avaloq nor Warburg Pincus provided comment on the matter.
One source characterized the dynamic as "a clash of a visionary co-founder who had trouble putting his plans into reality versus an experienced financial investor working through a fairly rigid three- to five-year investment case." This structural mismatch became particularly acute given Warburg Pincus's inability to enforce its strategic agenda without majority control, a critical constraint that hindered realization of its original investment thesis.
A structural impediment compounded the relationship's deterioration: the $367 million (350 million Swiss francs) that Warburg Pincus deployed in 2017 was structured as a share purchase from existing co-founders Francisco Fernandez and Ronald Straessler rather than a direct capital injection into Avaloq. Consequently, the company received no fresh capital and was forced to finance its strategic pivot from operating cash flow—a constraint that has contributed to Avaloq's profitability lagging behind competitors, as previously reported by finews.com.
Avaloq, advised by Goldman Sachs and Barclays, is conducting a formal sale process with an anticipated valuation target of approximately $2 billion. According to sources familiar with the matter, the company is expected to reach a decision on its disposition strategy within weeks of the June 24, 2020 reporting date. Neither Avaloq nor Warburg Pincus provided comment on the matter.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.